Every record from Nordanalyt · page 6
The slowest and most precise contributor. The only lab here offering ion-pair, SEC and ICP-MS as routine. Measured offset against the reference laboratory is -0.005 pp on 357 paired lots. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-019657 | SS-31 (Elamipretide) | Homopeptide | HOMO-2507-B2039 | 2025-Q4 | 99.67 | 5.51 | 100.9 | Supplier-supplied | 0 | PASS |
| AX-2025-018579 | BPC-157 | QYB | QYB-2506-B4999 | 2025-Q4 | 99.93 | 5.10 | 102.3 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019854 | Semaglutide | SWB | SWB-2511-B4697 | 2025-Q4 | 98.45 | 5.42 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020333 | BPC-157 | MKM | MKM-2506-D3139 | 2025-Q4 | 98.55 | 3.72 | 90.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018588 | ARA-290 | QYB | QYB-2511-Y5015 | 2025-Q4 | 99.93 | 5.39 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020269 | GHRP-2 | MKM | MKM-2506-K2643 | 2025-Q4 | 98.99 | 3.87 | 88.6 | Supplier-supplied | 2 | FAIL |
| AX-2025-018779 | Tirzepatide | QSC | QSC-2511-S7989 | 2025-Q4 | 99.60 | 4.32 | 102.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018484 | CJC-1295 with DAC | WWB | WWB-2509-J2816 | 2025-Q4 | 99.31 | 3.61 | 106.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020029 | CJC-1295 (no DAC) | ERP | ERP-2506-B7535 | 2025-Q4 | 99.04 | 5.52 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020160 | Liraglutide | GGPeps | GGPE-2505-W9629 | 2025-Q4 | 98.61 | 7.70 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019124 | IGF-1 DES (1-3) | JEEP | JEEP-2510-M4682 | 2025-Q4 | 99.83 | 3.14 | 107.4 | Supplier-supplied | 0 | PASS |
| AX-2025-019521 | MK-677 (Ibutamoren mesylate) | Homopeptide | HOMO-2506-L9801 | 2025-Q4 | 99.93 | 1.80 | 106.8 | Supplier-supplied | 1 | FAIL |
| AX-2025-019043 | GHRP-2 | JEEP | JEEP-2508-S3268 | 2025-Q4 | 99.38 | 3.48 | 97.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021254 | Cagrilintide | BCH | BCH-2509-A6666 | 2025-Q4 | 99.42 | 5.74 | 93.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021222 | BPC-157 | BCH | BCH-2508-H6138 | 2025-Q4 | 98.69 | 2.96 | 94.3 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020908 | GHRP-6 | CPC | CPC-2507-G2066 | 2025-Q4 | 99.93 | 6.94 | 100.1 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-019001 | PT-141 (Bremelanotide) | FGP | FGP-2509-H2645 | 2025-Q4 | 99.93 | 3.02 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019925 | IGF-1 LR3 | SWB | SWB-2505-N5257 | 2025-Q4 | 97.00 | 6.94 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019097 | BPC-157 | JEEP | JEEP-2505-J3812 | 2025-Q4 | 99.93 | 3.02 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019179 | AOD-9604 | TFC | TFC-2511-L5476 | 2025-Q4 | 99.56 | 3.70 | 92.0 | Laboratory-retained | 0 | PASS |
| AX-2025-018574 | Tirzepatide | WWB | WWB-2510-P4387 | 2025-Q4 | 99.30 | 3.67 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018805 | TB-500 | QSC | QSC-2507-J7717 | 2025-Q4 | 99.58 | 6.05 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018595 | GHRP-2 | QYB | QYB-2510-D4955 | 2025-Q4 | 99.26 | 4.00 | 99.8 | Supplier-supplied | 2 | FAIL |
| AX-2025-019588 | GHRP-6 | Homopeptide | HOMO-2508-W1724 | 2025-Q4 | 99.93 | 6.57 | 105.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019444 | GHRP-2 | Homopeptide | HOMO-2505-T8504 | 2025-Q4 | 99.75 | 5.28 | 95.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020152 | Semax | GGPeps | GGPE-2510-C9080 | 2025-Q4 | 98.89 | 8.04 | 100.0 | Laboratory-retained | 0 | PASS |
| AX-2025-019443 | Semaglutide | Homopeptide | HOMO-2511-G9197 | 2025-Q4 | 99.77 | 6.72 | 92.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018640 | Tirzepatide | QYB | QYB-2507-T5368 | 2025-Q4 | 99.40 | 6.29 | 104.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019517 | MK-677 (Ibutamoren mesylate) | Homopeptide | HOMO-2506-L9801 | 2025-Q4 | 99.78 | 1.30 | — | Laboratory-retained | 1 | FAIL |
| AX-2025-019891 | Selank | SWB | SWB-2511-C5170 | 2025-Q4 | 99.68 | 8.60 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020738 | Afamelanotide | SGN | SGN-2510-R8898 | 2025-Q4 | 97.92 | 5.10 | — | Buyer-sourced | 0 | FAIL |
| AX-2025-019401 | Tirzepatide | Homopeptide | HOMO-2510-E8656 | 2025-Q4 | 98.45 | 4.76 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019972 | BPC-157 | SWB | SWB-2511-N6092 | 2025-Q4 | 99.36 | 6.11 | 90.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018777 | Survodutide | QSC | QSC-2506-B8101 | 2025-Q4 | 98.41 | 5.60 | 91.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020915 | Pemvidutide | CPC | CPC-2507-H2201 | 2025-Q4 | 98.51 | 3.52 | — | Supplier-supplied | 3 | MARGINAL |
| AX-2025-018586 | ARA-290 | QYB | QYB-2511-Y5015 | 2025-Q4 | 99.58 | 5.55 | 94.7 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019168 | Semaglutide | TFC | TFC-2507-U5442 | 2025-Q4 | 99.06 | 4.43 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020474 | BPC-157 | KP | KP-2511-M5346 | 2025-Q4 | 98.80 | 4.70 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019379 | Tirzepatide | TFC | TFC-2503-P7552 | 2025-Q3 | 98.56 | 5.04 | 98.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021275 | Semaglutide | BCH | BCH-2505-Y7460 | 2025-Q4 | 97.94 | 6.40 | — | Supplier-supplied | 1 | MARGINAL |